Research & development is the fuel that sustains TAPI's leadership position. The R&D group at TAPI comprises a dedicated team of over 760 top scientists located in seven development centers worldwide. Our scientists specialize in the fields of chemical synthesis, fermentation, high potency, plant extraction, synthetic peptides, vitamin D derivatives, prostaglandins, and analytical and solid-state R&D.
Our profound ongoing investment in research & development generates a steady flow of API compounds, enabling the timely introduction of pharmaceutical products to market. Given the industry’s cost-conscious nature, about 50% of our R&D is dedicated to cost reduction through process efficiency and automation, empowering our customers to remain competitive in the global marketplace.